INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE SUPPRESS LIPOPOLYSACCHARIDE-INDUCED NITRITE FORMATION IN MACROPHAGES

被引:38
|
作者
HAUSCHILDT, S
SCHEIPERS, P
BESSLER, WG
机构
[1] Institute of Immunobiology, University of Freiburg
关键词
D O I
10.1016/0006-291X(91)91898-M
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stimulating bone marrow derived macrophages with LPS results in the induction of NO-synthase as measured by NO2- formation. Inhibitors of poly(ADP-ribose)polymerase, namely nicotinamide, 3-aminobenzamide and 3-methoxybenzamide, prevented NO2- formation in a dose dependent manner. Inhibition was most effective if the inhibitors were added at the same time as LPS. When added 10h after exposure to LPS, a time at which expression of the enzyme had reached its maximum, no inhibition was observed. The inhibitors also blocked early events in activation such as protein and RNA-synthesis as well as DNA-synthesis. Thus prevention of NO2- formation may be related to inhibition of these events. Activation of macrophages by LPS was not accompanied by an increase but rather by a small decrease in ADP-ribosyltransferase activity. Whether this decrease plays a physiological role in activation needs further exploration. © 1991.
引用
收藏
页码:865 / 871
页数:7
相关论文
共 50 条
  • [41] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Marek Banasik
    Todd Stedeford
    Robert P. Strosznajder
    Molecular Neurobiology, 2012, 46 : 55 - 63
  • [42] Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer
    Lewis, Cristina
    Low, Jennifer A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (12) : 1051 - 1056
  • [43] Targeting DNA repair: poly (ADP-ribose) polymerase inhibitors
    Frey, Melissa K.
    Pothuri, Bhavana
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 84 - 96
  • [44] Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages
    van Doorn, Cassandra L. R.
    Steenbergen, Sanne A. M.
    Walburg, Kimberley V.
    Ottenhoff, Tom H. M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] POLY(ADP-RIBOSE) POLYMERASE AND DNA
    YOSHIHARA, K
    SEIKAGAKU, 1981, 53 (07): : 528 - 534
  • [46] Poly(ADP-ribose) polymerase and aging
    Burkle, A
    EXPERIMENTAL GERONTOLOGY, 1998, 33 (06) : 519 - 523
  • [47] Trapping Poly(ADP-Ribose) Polymerase
    Shen, Yuqiao
    Aoyagi-Scharber, Mika
    Wang, Bing
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 353 (03): : 446 - 457
  • [48] Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
    Matanes, Emad
    Lopez-Ozuna, Vanessa M.
    Octeau, David
    Baloch, Tahira
    Racovitan, Florentin
    Dhillon, Amandeep Kaur
    Kessous, Roy
    Raban, Oded
    Kogan, Liron
    Salvador, Shannon
    Lau, Susie
    Gotlieb, Walter H.
    Yasmeen, Amber
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Poly(ADP-ribose) synthetase inhibition prevents lipopolysaccharide-induced peroxynitrite mediated damage in diaphragm
    Ozdülger, A
    Cinel, I
    Unlü, A
    Cinel, L
    Mavioglu, I
    Tamer, L
    Atik, U
    Oral, U
    PHARMACOLOGICAL RESEARCH, 2002, 46 (01) : 67 - 73
  • [50] POLY(ADP-RIBOSE) POLYMERASE-ACTIVITY AND POLY(ADP-RIBOSE) LEVELS AS A FUNCTION OF GROWTH
    LEVI, V
    JUAREZSALINAS, H
    FEDERATION PROCEEDINGS, 1980, 39 (06) : 2007 - 2007